Haemonetics Corp. buy Barrington Research
Start price
04.12.24
/
50%
€78.50
Target price
04.12.25
€102.93
Performance (%)
-45.22%
Price
17:15
€56.00
Summary
This prediction is currently active. Massive losses of -45.22% have been the result for the BUY prediction by Barrington_Research. This prediction currently runs until 04.12.25. The prediction end date can be changed by Barrington_Research at any time. Barrington_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | 2.392% | 2.392% |
| iShares Core DAX® | -0.170% | -1.242% |
| iShares Nasdaq 100 | -0.776% | 5.635% |
| iShares Nikkei 225® | 0.656% | 9.325% |
| iShares S&P 500 | -0.317% | 3.407% |
Comments by Barrington_Research for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $108.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by Barrington_Research for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€68.00
23.09.24
23.09.24
€97.01
23.09.25
23.09.25
-37.94%
24.09.25
24.09.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€88.50
10.05.24
10.05.24
€99.33
10.05.25
10.05.25
-29.38%
11.05.25
11.05.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€78.50
12.04.24
12.04.24
€98.71
12.04.25
12.04.25
-34.39%
13.04.25
13.04.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€66.00
13.02.24
13.02.24
€97.90
13.02.25
13.02.25
-11.36%
14.02.25
14.02.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€81.50
03.11.23
03.11.23
€97.80
03.11.24
03.11.24
-18.40%
04.11.24
04.11.24